A long-acting human growth hormone (VRS-317) in pre-pubertal children with growth hormone deficiency: A randomized, open-label, multi-center, phase 1b/2a study of safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy ...
|Effective start/end date||8/13/12 → 9/30/14|
- VERSARTIS, INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.